- Trials with a EudraCT protocol (44)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44 result(s) found for: E Selectin.
Displaying page 1 of 3.
EudraCT Number: 2006-001125-26 | Sponsor Protocol Number: ORG322 | Start Date*: 2006-08-04 |
Sponsor Name:University of Aberdeen | ||
Full Title: A randomised controlled trial of oral l-arginine supplementation on platelet and endothelial function and walking distance in patients with peripheral arterial disease | ||
Medical condition: Peripheral arterial disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001351-13 | Sponsor Protocol Number: APHP201133 | Start Date*: 2021-11-26 | |||||||||||
Sponsor Name:Assistance Publique des Hôpitaux de Paris(AP-HP) | |||||||||||||
Full Title: Interest of famotidine in reducing endothelial expression of P-selectin in children with sickle cell disease: pilot study, single-center, prospective, non-comparative | |||||||||||||
Medical condition: major sickle cell syndrome | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003168-28 | Sponsor Protocol Number: 77458 | Start Date*: 2022-06-28 |
Sponsor Name:Academic Medical Center (AMC), department of Internal Medicine | ||
Full Title: Impact of Triglyceride-Lowering on Inflammatory Activity in Patients with Hypertriglyceridemia | ||
Medical condition: - Hypertriglyceridemia - Inflammation - Lipoproteins | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019345-26 | Sponsor Protocol Number: 03-AnIt-10 | Start Date*: 2010-06-02 | |||||||||||
Sponsor Name:Department of Anesthesiology and Intensive Care, University Hospital Muenster | |||||||||||||
Full Title: Immunmodulatory effects of local anesthetics on neutrophils during sepsis | |||||||||||||
Medical condition: Sepsis and severe sepsis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-005174-23 | Sponsor Protocol Number: CAVA2Dec04 | Start Date*: 2005-04-11 |
Sponsor Name:NHS Grampian | ||
Full Title: Is smooth muscle mitogenesis down regulated by platelet inactivation with combination antiplatelet therapy after angioplasty for claudication? | ||
Medical condition: Intermittent claudication = stenosis of superficial femoral artery requiring percutaneous angioplasty | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002237-20 | Sponsor Protocol Number: ATS K021 | Start Date*: 2006-08-21 |
Sponsor Name:Takeda Pharma GmbH | ||
Full Title: Pilot trial studying the Effects of Pioglitazone in Comparison to Placebo on Myocardial Function and Oxidative Stress in Patients with Type II Diabetes and Insulin Resistance undergoing elective PTCA | ||
Medical condition: Type 2 diabetic patients treated with oral agents except PPAR gamma agonists and / or patients with insulin resistance measured by IRIS score > 50 with stable coronary artery disease and supposed e... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-005083-25 | Sponsor Protocol Number: GS-US-104-0318 | Start Date*: 2005-08-12 | |||||||||||
Sponsor Name:Gilead Sciences Incorporated | |||||||||||||
Full Title: A Phase IV, Randomized, Double-Blind, Placebo-Controlled Two-Phase Crossover Study of the Metabolic Impact of Tenofovir Disoproxil Fumarate on HIV 1 Seronegative Healthy Adult Males | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV-1) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005234-19 | Sponsor Protocol Number: | Start Date*: 2013-10-08 |
Sponsor Name:Blodbanken, Rigshospitalet | ||
Full Title: The effect of prostacyclin on haemostasis as evaluated by thrombelastography and endothelial markers in patients undergoing major abdominal surgery. A pilot study. | ||
Medical condition: Capillary leakage secondary to major surgical stress | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002981-11 | Sponsor Protocol Number: ThromboCa | Start Date*: 2013-09-24 | ||||||||||||||||
Sponsor Name:Medizinische Universität Wien, Klinik für Innere Medizin III, Abteilung für Gastroenterologie und Hepatologie | ||||||||||||||||||
Full Title: Iron Deficiency, Platelet Phenotype and Thromboembolism in Cancer Patients | ||||||||||||||||||
Medical condition: colorectal cancer, iron deficiency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003972-23 | Sponsor Protocol Number: hcc1 | Start Date*: 2009-01-09 | |||||||||||||||||||||
Sponsor Name:LUMC | |||||||||||||||||||||||
Full Title: Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment | |||||||||||||||||||||||
Medical condition: The primary objective of this study is to determine the efficacy of the combination of everolimus and capecitabine in a group of patients with metastatic or locally advanced HCC. In addition, to in... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003859-12 | Sponsor Protocol Number: 12-027 | Start Date*: 2013-07-19 | ||||||||||||||||
Sponsor Name:RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A) | ||||||||||||||||||
Full Title: Linagliptin as a modulator of vascular inflammation in patients with type 2 diabetes mellitus | ||||||||||||||||||
Medical condition: patients with type 2 diabetes mellitus and vascular inflammation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001305-41 | Sponsor Protocol Number: MicroVasc-DIVA | Start Date*: 2014-11-25 |
Sponsor Name:GWT-TUD GmbH | ||
Full Title: MICROVASCULAR AND ANTIINFLAMMATORY EFFECTS OF RIVAROXABAN COMPARED TO LOW DOSE ASPIRIN IN TYPE 2 DIABETIC PATIENTS WITH VERY HIGH CARDIOVASCULAR RISK AND SUBCLINICAL INFLAMMATION | ||
Medical condition: Patients with type 2 diabetes and stable cardiovascular disease (CVD) and low grade inflammation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-004537-19 | Sponsor Protocol Number: 2008-004537-19 | Start Date*: 2009-08-03 | ||||||||||||||||||||||||||
Sponsor Name:Karolinska Universitetssjukhuset | ||||||||||||||||||||||||||||
Full Title: Effekt av insulininfusion på sjukdomsförloppet vid infekterade fotsår samt vid thorax- och kärlkirurgi hos patienter med diabetes | ||||||||||||||||||||||||||||
Medical condition: diabetes mellitus infekterat fotsår kärl eller thoraxkirurgisk operation | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000328-85 | Sponsor Protocol Number: FINNHT1 | Start Date*: 2017-05-18 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Helsinki University Hospital, Obstetrics and Gynecology | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Randomized comparative trial between abrupt and tapered mode of discontinuation of longterm hormone therapy: Impact on endothelial function, recurrence of vasomotor symptoms and quality of life | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: We will assess the effects of hormone therapy termination on endothelial function using biophysical (flow-mediated dilation, peripheral artery tonometry) and biochemical markers. We will compare th... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012676-27 | Sponsor Protocol Number: FemExp-I | Start Date*: 2010-01-24 | ||||||||||||||||
Sponsor Name:Wallenberg laboratory | ||||||||||||||||||
Full Title: Femoral-Express-I | ||||||||||||||||||
Medical condition: Peripheral artery disease. Patients due for by-pass surgery of lower extremity arteries. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005220-15 | Sponsor Protocol Number: IIS-1-025R-NL_Kamphuisen | Start Date*: 2013-10-23 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early diabetes | |||||||||||||
Medical condition: type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006887-44 | Sponsor Protocol Number: RGHT000396 | Start Date*: 2007-06-19 | |||||||||||
Sponsor Name:Royal Group Hospitals Trust | |||||||||||||
Full Title: Non-invasive bed-side measurement of systemic endothelial function in patients undergoing abdominal aortic aneurysm repair; modulation by ascorbic acid | |||||||||||||
Medical condition: Abdominal Aortic Aneurysm | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003698-25 | Sponsor Protocol Number: RHMMED1063 | Start Date*: 2013-02-26 | |||||||||||
Sponsor Name:University Hospital Southampton NHS Foundation Trust | |||||||||||||
Full Title: Proof of concept clinical trial examining the effect of clopidogrel on allergen challenge in asthma | |||||||||||||
Medical condition: asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018369-48 | Sponsor Protocol Number: CASTIP3 | Start Date*: 2011-03-10 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Der Einfluss von Adalimumab auf kardiovaskuläre und metabolische Risikofaktoren in der Therapie von Patienten mit mittelschwerer bis schwerer Psoriasis vulgaris im Vergleich zu einer Standardtherap... | |||||||||||||
Medical condition: Psoriasis vulgaris | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003175-19 | Sponsor Protocol Number: U1111-1206-7541 | Start Date*: 2019-11-28 | |||||||||||
Sponsor Name:Steno Diabetes Center Copenhagen | |||||||||||||
Full Title: Renal effects of treatment with Empagliflozin alone or in combination with Semaglutide in patients with type 2 diabetes and albuminuria - A double blinded, randomised, placebo controlled, parallel... | |||||||||||||
Medical condition: Type 2 diabetes with renal complications | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.